Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients addicted to cocaine (according to the DSM V classification)~* Patients admitted for three weeks in the unit 73 of the CHU Brugmann Hospital~* French speaking~Exclusion Criteria:~* Anti-craving or anti-psychotic medication~* Addiction to other drugs (except nicotine or cannabis)~* Neurological medical history~* Psychiatric medical history~* Heavy medical history~* Asthma~* Pregnancy~* Lactose intolerance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- N-acetylcysteine (Type: EXPERIMENTAL): None
- Lactose powder (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).